News

Cannabis Research: Cancer Posted on 15 Jan 13:45

Cancer is a large group of diseases, which results in uncontrolled and rapid cell growth. Due to the uncontrolled growth of the cancer cells invade the surrounding healthy tissue and destroy it. Cancer usually starts in one part of the body, but can spread through the bloodstream and lymphatic system. There are more than 200 types of cancer that occur in humans, which all have different symptoms, depending on where they are located.
Brain cancer studies:
1) Anti-tumor effects of cannabidiol, a non-psychoactive cannabinoid, on human glioma cell lines (anti-tumor effects of cannabidiol, a cannabinoid Nonpsychoactive, on Human Glioma Cell Lines - 2003)
Under laboratory conditions, research has been conducted in order to investigate the hypothesis that CBD have anti-tumor properties. It was found that CBD is the viability of the tumor cells dropped significantly, suggesting that CBD is an effective antitumor agent. Published in the "Journal of Pharmacology and Experimental Therapeutics."
2) Neuroprotection by Δ9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain induced by excitotoxicity in the living organism (Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo excitotoxicity - 2001)
This research was designed to investigate the effects of THC on acute brain damage and brain degenerative diseases. It has been found that THC has an effect that protects the brain from degenerative diseases. Published in the "Journal of Neuroscience."
3) A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme (A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme - 2006)
This study was the first that was designed to explore the antitumor properties of cannabinoids in a clinical setting. She came to positive results, and it was found that THC and other cannabinoids inhibit tumor growth in patients. Published in the "British Journal of Cancer."
4) A combined preclinical therapy of cannabinoids and temozolomide against glioma (A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma - 2011)
This research aimed to evaluate the use of THC in conjunction with the drug TMZ in the treatment of glioblastoma multiforme - the most common and very resistant form of brain cancer. It has been found that the combined treatment showed that the reversed-tumor activity. Published in the journal "Molecular Cancer Therapeutics."
Breast cancer studies:
1) Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma (anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma - 2006)
This research recognizes the antitumor effects of THC, but claims that it was problematic because of its psychoactive properties. Therefore, they went on to assess the effects of other cannabinoids. It was found that CBD showed promising anticarcinogenic characteristics that should be investigated further. Published in the "Journal of Pharmacology and Experimental Therapeutics."
2) pathways in mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion and metastasis (Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis - 2010)
This study was designed to determine the effects of CBD on breast cancer cells. It was found that it inhibited the growth and the spread of these cancer cells. It has also been discovered that CBD significantly reduced the tumor mass. Published in the "U.S. Library of Medicine."
3) Cannabinoids reduce ErbB2-driven breast cancer progression through AKT inhibition (Cannabinoids reduce ErbB2-driven breast cancer progression through AKT inhibition - 2010)
This research describes experiments that were performed to assess the effects of cannabinoids on the very aggressive ERB2-positive breast cancer. They concluded that cannabinoids both tumor growth, as well as the amount of existing tumors appeared to decrease, which strongly suggests that they represent a real application for the therapeutic treatment of breast cancer. Published in the journal "Molecular Cancer."
4) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation (The endogenous cannabinoid anandamide Inhibits human breast cancer cell proliferation - 1998)
This research was designed to investigate the effects of cannabinoids on the proliferation of breast cancer cells. It has been found to inhibit the growth. Published in the "National Academy of Sciences (PNAS)."
Lung cancer studies:
1) Δ9-Tetrahydrocannabinol inhibits both triggered by the epithelial growth factor lung cancer cell migration outside of the living organism, as well as the growth and metastasis in the living organism (Δ9-Tetrahydrocannabinol Inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo - 2008)
This research was conducted to study the effects of THC to the epithelial growth factor induced by cancer - a particularly aggressive and resistant to chemotherapy form of cancer. It was found that THC has played a significant role in inhibiting cancer growth, which justifies further research in this direction. Published in the journal "Oncogene."
2) Cannabidiol inhibits lung cancer cell invasion and metastasis via the intercellular adhesion molecule-1 (Cannabidiol Inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1-2011)
In this research, it was tried to examine the effects of CBD on the invasiveness of cancer. It has been found that cannabinoids inhibit the invasiveness of the primary tumor cells in patients with lung cancer. Published in the "U.S. National Library of Medicine."
3) The cannabinoid receptors CB1 and CB2 as new targets for the inhibition of large cell lung cancer growth and metastasis (cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis - 2011)
This research was conducted to determine the role of the cannabinoid receptor activation in lung cancer. It has been found that both inhibit the growth of cancer cells and enhance their apoptosis - the natural process of cell death. Published in the "U.S. National Library of Medicine."
Prostate cancer studies:
1) Anti-proliferative and apoptotic effects of anandamide in human Prostatakrebszellinien: implication of the reduction of epidermal growth factor receptors and ceramide production (anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production - 2003)
This study describes how the activation of cannabinoid receptors causes an antiproliferative effect in cancer cells in the prostate, which has major implications for the treatment of prostate cancer. Published in the "U.S. National Library of Medicine."
2) The role of cannabinoids in prostate cancer: basic scientific point of view and possible clinical applications (The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications - 2012)
This study conducted a multi-evaluation of many other previous research on prostate cancer to determine whether cannabinoids have a practical clinical application. It has been found that it is in everyone's best interest to conduct clinical trials of medical cannabis. Published in the "U.S. National Library of Medicine."
3) Non-THC Cannabinoids inhibit prostate cancer growth in vitro and in vivo: Pro-apoptotic effects and the underlying mechanisms (non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms - 2013)
This research was designed to extend the previously explored idea that cannabinoid receptor activation causes cell death in prostate cancer cells. The research found significant positive results and found that the data supported the clinical tests of CBD from prostate cancer patients. Published in the "U.S. National Library of Medicine."
Blood cancer studies:
1) cannabinoid receptor-mediated apoptosis induced by R (+)-methanandamide and WIN55 0.212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma (Cannabinoid Receptor-Mediated Apoptosis Induced by R (+)-Methanandamide and WIN55, 212 - 2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma - 2006)
This research was designed to explore whether cannabinoids inhibit cancer cells in lymphomas. It describes that it has been found that cannabinoids inhibit the growth and induce cell death in mantle cell lymphoma (blood cancer). Published in the journal "Molecular Pharmacology."
2) triggered by Δ9-tetrahydrocannabinol apoptosis in Jurkat T-leukemia cells is regulated by the translocation of BAD mitochondria. (Δ9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria - 2006)
This research discusses how the use of cannabinoids in apoptosis (regulated and the natural death of cells) is to be evaluated. They yielded positive results, and it was found that cannabinoids actually cause the death of carcinogenic leukemia cells. Published in the "U.S. National Library of Medicine."
3) Activation of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation (expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation - 2008)
This research aimed to determine the effects of the cannabinoid receptor activation on lymphomas. It has been found that the cannabinoid receptor activation, the multiplication and growth of lymphoma reduced, and causes the death of some cancer cells. Published in "International Journal of Cancer."
Oral cancer studies:
Cannabinoids inhibit cellular respiration of human oral cancer cells (Cannabinoids inhibit cellular respiration of human oral cancer cells - 2010)
This research was aimed to investigate the effects of cannabinoids on cell respiration in certain types of oral cancer. It has been found that cannabinoids inhibit cancer cell respiration and therefore have a toxic effect on them. This implies that cannabinoids may be used for the treatment of oral cancer. Published in the "U.S. National Library of Medicine."
Liver cancer studies:
Anti-tumor effect of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy (Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy - 2011)
This research aimed to determine what the effects of THC on cancer cells in the liver. It has been found that the growth of THC and the effectiveness of these cancer cells is reduced, which means that THC should be further examined as a therapeutic treatment. Published in the "U.S. National Library of Medicine."
Pancreatic cancer studies:
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes (Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress-Related Genes - 2006)
This study suggests that pancreatic tumor tissue seems to have a much higher number of cannabinoid receptors compared to normal pancreatic tissues. The study found that, when the cannabinoids are administered to cancer cells began to die by apoptosis, resulting in a reduction in the growth and spread of the tumor. Published in "The American Journal of Cancer."


"New York Times" calls for cannabis legalization Posted on 15 Jan 13:29

cannabis legalization

The "New York Times" is one of the most respected media outlets in the USA for the legalization of cannabis has spoken. In a sensational editorials have been for more than four decades valid prohibition with the times of Prohibition, from 1920 to 1933 is compared, were prohibited as manufacture and sale of alcohol in the United States strictly. It stated cannabis addiction bring compared to alcohol and tobacco dependence "relatively minor problems" with it.

In the editorial, the authors pointed out that pleasure-loving people would have been on drinking during Prohibition, which "law-abiding citizens have been turned into criminals and crime syndicates flourished." In addition, today were young black men, according to FBI statistics clearly bear the brunt of the result is "racist" cannabis prohibition.

According to the U.S. Federal Bureau of Investigation in 2012, there were over 650,000 arrests for possession of marijuana - much more than cocaine, heroin and related drugs. U.S. President Barack Obama had already indicated that poor youth who belong to social minorities, often for marijuana use in jail migrate as better-off peers.

Although the "New York Times" said in her - even for internal editorial controversial - contribution for a ban on the sale of marijuana to adolescents under 21 years. For healthy adults seem "moderate consumption" but to pose a risk, which is why the law adopted by Congress at the federal level more than four decades prohibition was untimely. On the website of the newspaper some readers warned against underestimating the danger of the popular "gateway drug", others called the legalization overdue.


cannabidiol (CBD) in Focus Posted on 15 Jan 13:22

cannabidiol (CBD)

This is, interestingly, not as standard practice moved as cannabis ingredient THC into the center, but the cannabidiol (CBD).
Tetrahydrocannabinol (THC) is always shown as the main active ingredient in cannabis. But cannabis contains 66 different cannabinoids with different modes of action.
For THC the therapeutic use in some situations is difficult by the intoxicating effect. In addition, do not reach all patients with a pure THC preparation - in Switzerland as dronabinol in trade - a satisfactory treatment outcome.
Unlike THC CBD developed no psychoactive “high.” effect.
On the contrary, according to recent studies, CBD should neutralize the psychoactive effect of the THC's or at least slow down. Moreover, it should also have a cancer and anti-inflammatory effect. Already known for some time was its anticonvulsant, anxiolytic, and nausea-relieving effect. In addition, CBD is only slightly toxic and has few side effects, emphasizes the pharmacist Rudolf cautery, a specialist in cannabis at the University of Bern.
For a long time the research around the use of cannabis in medicine, according to cautery has mainly focused on the active ingredient THC. Cannabinoids have been used primarily to treat neurological disorders such as multiple sclerosis or epilepsy, against the side effects of chemotherapy or for chronic pain. The discovery of the CBD and its potency of cannabis gave new impetus to international research, says branding iron. For the natural remedies cannabis thereby always open new research approaches, such as the application in breast cancer, or psychosis. Medicinalcannabis has become increasingly important in recent years.

One consequence of this cannabis research is the introduction of Sativex - a drug with a combination of THC and CBD, may contribute to relief of pain and discomfort in multiple sclerosis.


Cannabis Research: Urinary incontinence Posted on 21 Dec 08:34

Cannabis Research: Urinary incontinence

Urinary incontinence

Urinary incontinence is the loss of control of the bladder, usually due to weak muscles, inflammation or nerve damage. It is mostly related to MS or Parkinson's disease.
Studies in this area:
1) A preliminary controlled study to determine whether cannabis extracts of the whole plant to improve persistent neurogenic symptoms (A preliminary controlled study to deterministic mine Whether whole-plant cannabis extracts can Improve intractable neurogenic symptoms - 2003)
This research aimed to find out whether the use of cannabis extracts would improve symptoms of MS, such as urinary incontinence, pain and spasticity. It was found that the use of cannabis appeared to improve symptoms that would otherwise respond to any other treatments more. It was also noted that the medically undesirable psychedelic symptoms occurred, though, but they were well tolerated. Published in the "U.S. National Library of Medicine."
2) An open pilot study of cannabis extracts for bladder dysfunction in advanced multiple sclerosis (n open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis - 2004)
This study was designed to verify the personal opinions that marijuana can help alleviate symptoms of Harnwegproblemen that were caused by MS. It has been found that the use of marijuana reduced the number of incontinence episodes, and the precipitated amount. In addition, it was reported that patients tended to have less pain and spasticity and sleep improved. Published in the "Multiple Sclerosis Journal".

 

 

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.


Cannabis in Western medicine Posted on 20 Dec 07:59

 

 

Cannabis in Western medicine

"For cancer patients it comes as a side effect of chemotherapy often too great nausea and vomiting. Moreover, already alone the smell of food can be unbearable, so it only with great overcoming is possible many cancer patients ever receive food. Cannabis can soothing by its anti-emetic (nausea ) Effect reduce this nausea and passing through its appetizing effect to a desired weight gain. many countries THC are now (= dronabinol)-containing preparations such as the and the U.S. coming Marinol available as prescription drugs for patients. However, many patients believe that gerauchtest Cannabis works much better, which is due to the unique combination of active ingredients in the cannabis plant. However, this application is still illegal.

Also in AIDS therapy you can make the appetizing effect of cannabis advantage. In addition to therapy, it is namely often a lack of food intake, which weakens the body additionally. In addition, cannabis can distract the patient and bring a sentiment with positive attitude. Also glaucoma in which the intraocular pressure is greatly increased, which can lead to blindness can be treated with cannabis. Without surgical intervention, alone by smoking cannabis, the intraocular pressure can be lowered to normal values. For this effect is not the psychoactive THC responsible, but that hardly psychoactive substances CBN (cannabinol) and CBD (cannabidiol). Therefore, can be a therapeutic application with low-THC hemp products. Cannabis also has ataxia (movement coordinator) effect, as well as an antispasmodic, so Muscle relaxation, which makes it a good means for suppressing spasms, paralysis and convulsions, as they occur in multiple sclerosis. It can not cure the disease, but suppress the symptoms of the disease and facilitate the patient as his life. Asthma attacks can be stopped by a few traits of a joint often. Criticism here is the damage to the lungs, which of course plays an important role in asthma attacks. Remedy is here to create an inhaler that is being developed. Even a mild antibiotic effect has an ingredient that the CBD. Further acting antiepileptic cannabis, thereby epileptics while cannabis administration, the dose of medication can be reduced. Cannabis may also be used for the treatment of different pain, headache, migraine and menstrual cramps. Also in obstetrics Cannabis can be used as an alternative, as it can lead to an increased frequency of contraction of the uterus and hemostasis. In Africa and Asia, this application is used in folk medicine to this day.

 

 

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.


Cannabis is acceptable as a medicinal plant Posted on 20 Dec 07:42

Cannabis is acceptable as a medicinal plant

Cannabis


Much speaks for their great potential as a medicinal plant - here's momentum in the research of hemp. And also waiting on the market for the first drugs with cannabis as a drug for the start.


Recently, the American television station CNN has reported in a lurid story about the fate of the seven-year-old Charlotte from the state of Colorado. She suffers from a very rare but cruel form of epilepsy, the Dravet syndrome. The disease begins in the first few months of life and is associated with partially over a hundred seizures a day that are medically barely treatable. The disease prevents normal development, a mental disability is the result. Meanwhile, Charlotte has the ability to walk, talk and eat almost entirely lost. Conventional medicine was at her wit's end. They even considered to put the child in an induced coma to allow his body a rest.

The father, meanwhile, sought diligently for a therapy that promises relief from his child - until he came across the illegal cannabis. After he had heard that a boy was successfully treated with Dravet syndrome in California so he wanted this therapy must have for Charlotte. Charlotte received a dissolved in oil cannabis extract of the active ingredients tetrahydrocannabinol (THC) and especially cannabidiol (CBD). The effect was striking: the spasms died within a few hours, and decreased to about one seizure per week - and that, without the child was high.

Rudolf cautery, pharmacist and specialist for cannabis at the University of Bern, reporting on CNN followed closely. About the amazing effect he was less surprised. Since he started in the mid-1990s with the cannabis research as a Swiss pioneer, he was able to observe such effects. Exciting, however, he found the fact that with such contributions cannabis'm getting acceptable and had been pre-CBD, a component of Hanfplanze without noise effect addressed.
Momentum in research. For a long time the research around the use of cannabis in medicine has focused mainly on the active ingredient THC, according to cautery. However, its application is a problem mainly because of the intoxicating effect. While CBD, as recently discovered, neutralizes this effect, or at least reduced and in addition also has a cancer and anti-inflammatory effect. Been known for is its anticonvulsant, anxiolytic, and nausea-relieving effect. "Besides, it has a low toxicity and few side effects," says the pharmacist.

THC and CBD are among the 66 cannabinoids to the most promising therapeutic agents. Cannabinoids have been used primarily to treat neurological disorders such as multiple sclerosis or epilepsy, against the side effects of chemotherapy or for chronic pain. The discovery of the CBD and its potency was loud cautery of the International Cannabis Research new impetus. For the natural remedies cannabis always open new research approaches, such as the application in breast cancer, or psychosis. Medizinalcannabis place in recent years more and more recognition. The strict prohibition of cultivation, trade and consumption of hemp, especially Medizinalcannabis is increasingly relaxed in many countries (see box right).
Austrians have to wait. So a cannabis preparation was in France recently for the first time allowed the manufacturer GW Pharmaceuticals Sativex. The two active components THC and CBD contained therein promise relief from the pain and discomfort in multiple sclerosis. In the spring also an approval of the same drug in Switzerland is expected. And since 2005, the Dutch company Bedrocan officially sells cannabis medicines.

Meanwhile, politics and society do in Austria still quite difficult. "Due to the legal situation in Austria there are no research with natural cannabinoids," explains Kurt Blaas, a general practitioner with extensive experience in drug therapy and chairman of the Association for Cannabis as Medicine. Universities also investigated not, although he would be granted an exception. Since the early 1990s, however, dronabinol - synthetic THC - are prescribed simply by prescription. Likewise, it is noisy and a half years since Blaas possible to deliver in certain indications such as multiple sclerosis Sativex by insurances - also in Germany have MS now this possibility.
Proof of efficacy difficult. Nevertheless, the cannabis specialist wishes finally a "decriminalization, perhaps even the partial legalization of consumption and trade." After all, he points out: "The use of natural cannabinoids that are produced under controlled conditions, is suitable for medical use." Especially since there are also many patients who then asked specifically, especially in the cancer field. Political advances have so far yielded little success, a petition with nearly 6,000 signatures from patients and interested parties was also deposited with the government parties.

Not only the legal-political situation has so far prevented that the pharmaceutical industry has entered in a big way. The research prepares the proof of efficacy of cannabis difficulties, which is often contradictory, in contrast to the many non-academic experience reports. This is related to the pharmaceutical chemist in accordance with the internal iron complex functions of endogenous cannabinoid system include all mammals, and which plays an important role in a disease process.

So presented in the spring of last year, a molecular biologist Cristina Sánchez carried out in Tenerife study in which a brain tumor had been treated with THC. The result: The THC triggered the death of the cancer cells and prevented the formation of new cancer cells.

It is worth noting was mainly that the THC was not directly effective, but that it stimulated endogenous cannabinoids to be more active. The validity of this study is limited because only a small number of patients was tested. The same effect is achieved THC in the context of animal tests also against an aggressive type of breast cancer. However Secured is also nothing here, because in contrast to other animal testing cannabinoids lung and breast tumors could be even greater.

 

 

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.


Prostate Cure with cannabis Posted on 19 Dec 15:07

Prostate Cure with cannabis

medical marijuana

The positive effect of cannabis indica (marijuana) for the cure of prostate cancer is known in the U.S. for at least 30 years. Cannabinoids inhibit the growth of cancer cells, without attacking healthy cells. You can also nausea and relieves pain, stimulate the appetite and improve mood.
Cannabis and Cancer
At the University of Alcala in Madrid under the direction of Ines Diaz-Laviada a study on the effects of cannabis was conducted on the healing of prostate cancer. Outcome of study (also by experiments on living laboratory mice confirmed) was published in the British Journal of Cancer: the growth of prostate cancer cells under the effect of cannabinoids has slowed down significantly. Cannabinoids block obviously a receptor on the surface of cancer cells and stop them in this way because to continue to divide and grow.
The scientists at the California Pacific Medical Center in San Francisco have examined the effect of cannabidiol, CBD short, on the gene ID-1. CBD is considered to be weak psychoactive cannabinoid from the female hemp. The gene ID-1 is responsible for the outbreak of cancer and the spread of diseased cells. CBD should be able to stop the growth of metastases in aggressive cancers. Under the influence of the cannabinoid cancer cells have ceased to spread and regressed back to normal cells. The researchers tested the relationship for the time being in breast cancer. In the course of their investigations, however, revealed that CBD is also effective for brain tumors or prostate cancer.
Meanwhile also the pharmacologist from the University Hospital Rostock, the anti-cancer activity of cannabinoids demonstrated (University of Rostock 05.02.2008). The researchers Dr. Robert Ramer and Dr. Burkhard Hinz has managed to prove that cannabinoids also block the penetration (invasion) of tumor cells into the surrounding tissue. With the invasion of cancer cells can enter the blood and lymphatic system and enter from there into other body tissues to form secondary tumors (metastases). Tumor cell invasion is facilitated by certain enzymes. The Rostock researchers have shown that cannabinoids cause the human genetic apparatus to produce an endogenous inhibitor of these enzymes, which suppresses the invasiveness.
A plurality of further studies on cells and animals have shown that several cannabinoids including THC the growth of several cancers, inhibit, for example, breast cancer, skin cancer, lung cancer, lymphoma, uterine cancer and prostate cancer.
Interestingly, also inhibited the cannabinoids which cause no psychological effects, the growth of tumors. This includes the natural cannabidiol (CBD), which predominates in fiber hemp.
A study of two glioblastoma cell lines (malignant brain tumor), has shown that a combination of THC and CBD led to specific anti-tumor effects that were not observed with a dose of the individual substances. These results suggest that a combination of CBD and THC could improve the overall effectiveness of THC in the treatment of glioblastoma in humans.
A cannabis plant that has similar little THC and CBD is much as Cannatonic or diesel Tonic by Resin Seeds breeder, an indica / sativa hybrid.
Cannatonic test values: 8.83% THC, THCA 7.83%, CBD 5.6%, 0.4% CBC, CBG 0.4%
Diesel Tonic relatives with Cannatonic and has 50% plant THC / CBD ratio 1:1.
Although you can apply all types of cannabis for medical purposes, some varieties are better suited for specific conditions than others. In this section, the varieties are listed which can be used as medical varieties particularly well. The following information is intended only as guidelines. Anyone who wants to use cannabis for medicinal purposes, should seek the advice of a qualified physician before.
The medical cannabis Indica strains have a high proportion of CBD and THC. Cannabidiol (CBD) causes a more soothing "Stoned" feeling with an emphasis on the body, which helps the patient to relax, because his muscle tension decreases. The most effective are Indicas in the treatment of tremors and muscle spasms (including the tremor due to multiple sclerosis and chronic pain,Parkinson's disease), arthritic and rheumatic stiffness and inflammation,anxiety insomnia and related conditions.
The Cannabis Sativa varieties tend to have a high THC and lower CBD content, which manifests itself rather than energetic "high" effect that is evident both in the brain and in the body. These medical varieties are most effective in the treatment of nausea (for example as a result of chemotherapy or HIV / AIDS drugs), stimulate the appetite and help with migraines, depression, chronic pain and related symptoms.
The hybrids from medical Indica and Sativa varieties offer many clear patient benefits. Because the combination of Sativagenen with a predominantly shaped by the Indica variety promotes mental clarity and reduces sleep-inducing effects, while the enclosing some Indicagene a Sativa dominated by the species may dampen the tendency of pure sativas to excite fears.
Some hybrids that mix an Indica with wild Ruderalis varieties contain high levels of CBD and relatively low levels of THC. These varieties are particularly suitable for patients who appreciate the medical healing effects of CBD over the psychotropic properties of THC.
Also cannabis in raw form, as a salad or tea shows its effect. Too, the industrial use of hemp fiber contains cannabidiol, CBD. CBD is not prohibited in contrast to THC in most countries. The active ingredient THC is the most in the resin of the flowers of the female hemp plant, followed by CBD. In the industrial use of hemp, the THC has been almost bred out, in the EU a maximum value of 0.3% THC applicable in the plant mass. In the plant, CBD is linked to water before and CBD acid. CBD acid is not psychoactive.
 
 
 
 THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.